High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity

Excess salt intake could affect the immune system by shifting the immune cell balance toward a pro-inflammatory state. Since this shift of the immune balance is thought to be beneficial in anti-cancer immunity, we tested the impact of high salt diets on tumor growth in mice. Here we show that high s...

Full description

Bibliographic Details
Main Authors: Ralf Willebrand, Ibrahim Hamad, Lauren Van Zeebroeck, Máté Kiss, Kirsten Bruderek, Anneleen Geuzens, Dries Swinnen, Beatriz Fernandes Côrte-Real, Lajos Markó, Els Lebegge, Damya Laoui, Josephine Kemna, Thomas Kammertoens, Sven Brandau, Jo A. Van Ginderachter, Markus Kleinewietfeld
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01141/full
id doaj-bfe4fc0328934a64ba739cb53f48cf52
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ralf Willebrand
Ibrahim Hamad
Lauren Van Zeebroeck
Máté Kiss
Máté Kiss
Kirsten Bruderek
Anneleen Geuzens
Dries Swinnen
Beatriz Fernandes Côrte-Real
Lajos Markó
Els Lebegge
Els Lebegge
Damya Laoui
Damya Laoui
Josephine Kemna
Josephine Kemna
Thomas Kammertoens
Thomas Kammertoens
Sven Brandau
Jo A. Van Ginderachter
Jo A. Van Ginderachter
Markus Kleinewietfeld
spellingShingle Ralf Willebrand
Ibrahim Hamad
Lauren Van Zeebroeck
Máté Kiss
Máté Kiss
Kirsten Bruderek
Anneleen Geuzens
Dries Swinnen
Beatriz Fernandes Côrte-Real
Lajos Markó
Els Lebegge
Els Lebegge
Damya Laoui
Damya Laoui
Josephine Kemna
Josephine Kemna
Thomas Kammertoens
Thomas Kammertoens
Sven Brandau
Jo A. Van Ginderachter
Jo A. Van Ginderachter
Markus Kleinewietfeld
High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
Frontiers in Immunology
cancer
dietary factor
MDSC
cancer immunotherapy
sodium chloride (dietary)
author_facet Ralf Willebrand
Ibrahim Hamad
Lauren Van Zeebroeck
Máté Kiss
Máté Kiss
Kirsten Bruderek
Anneleen Geuzens
Dries Swinnen
Beatriz Fernandes Côrte-Real
Lajos Markó
Els Lebegge
Els Lebegge
Damya Laoui
Damya Laoui
Josephine Kemna
Josephine Kemna
Thomas Kammertoens
Thomas Kammertoens
Sven Brandau
Jo A. Van Ginderachter
Jo A. Van Ginderachter
Markus Kleinewietfeld
author_sort Ralf Willebrand
title High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
title_short High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
title_full High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
title_fullStr High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
title_full_unstemmed High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
title_sort high salt inhibits tumor growth by enhancing anti-tumor immunity
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-06-01
description Excess salt intake could affect the immune system by shifting the immune cell balance toward a pro-inflammatory state. Since this shift of the immune balance is thought to be beneficial in anti-cancer immunity, we tested the impact of high salt diets on tumor growth in mice. Here we show that high salt significantly inhibited tumor growth in two independent murine tumor transplantation models. Although high salt fed tumor-bearing mice showed alterations in T cell populations, the effect seemed to be largely independent of adaptive immune cells. In contrast, depletion of myeloid-derived suppressor cells (MDSCs) significantly reverted the inhibitory effect on tumor growth. In line with this, high salt conditions almost completely blocked murine MDSC function in vitro. Importantly, similar effects were observed in human MDSCs isolated from cancer patients. Thus, high salt conditions seem to inhibit tumor growth by enabling more pronounced anti-tumor immunity through the functional modulation of MDSCs. Our findings might have critical relevance for cancer immunotherapy.
topic cancer
dietary factor
MDSC
cancer immunotherapy
sodium chloride (dietary)
url https://www.frontiersin.org/article/10.3389/fimmu.2019.01141/full
work_keys_str_mv AT ralfwillebrand highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT ibrahimhamad highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT laurenvanzeebroeck highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT matekiss highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT matekiss highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT kirstenbruderek highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT anneleengeuzens highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT driesswinnen highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT beatrizfernandescortereal highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT lajosmarko highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT elslebegge highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT elslebegge highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT damyalaoui highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT damyalaoui highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT josephinekemna highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT josephinekemna highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT thomaskammertoens highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT thomaskammertoens highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT svenbrandau highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT joavanginderachter highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT joavanginderachter highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
AT markuskleinewietfeld highsaltinhibitstumorgrowthbyenhancingantitumorimmunity
_version_ 1725320865226162176
spelling doaj-bfe4fc0328934a64ba739cb53f48cf522020-11-25T00:32:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-06-011010.3389/fimmu.2019.01141452773High Salt Inhibits Tumor Growth by Enhancing Anti-tumor ImmunityRalf Willebrand0Ibrahim Hamad1Lauren Van Zeebroeck2Máté Kiss3Máté Kiss4Kirsten Bruderek5Anneleen Geuzens6Dries Swinnen7Beatriz Fernandes Côrte-Real8Lajos Markó9Els Lebegge10Els Lebegge11Damya Laoui12Damya Laoui13Josephine Kemna14Josephine Kemna15Thomas Kammertoens16Thomas Kammertoens17Sven Brandau18Jo A. Van Ginderachter19Jo A. Van Ginderachter20Markus Kleinewietfeld21VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, BelgiumVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, BelgiumVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, BelgiumCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, BelgiumMyeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, BelgiumResearch Division, Department of Otorhinolaryngology, West German Cancer Center, University Hospital Essen, Essen, GermanyVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, BelgiumVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, BelgiumVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, BelgiumExperimental and Clinical Research Center, A Joint Cooperation of Max Delbrück Center for Molecular Medicine and Charité University Medicine Berlin, Berlin, GermanyCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, BelgiumMyeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, BelgiumCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, BelgiumMyeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, BelgiumInstitute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, GermanyMax Delbrück Center for Molecular Medicine, Berlin, GermanyInstitute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, GermanyMax Delbrück Center for Molecular Medicine, Berlin, GermanyResearch Division, Department of Otorhinolaryngology, West German Cancer Center, University Hospital Essen, Essen, GermanyCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, BelgiumMyeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, BelgiumVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, BelgiumExcess salt intake could affect the immune system by shifting the immune cell balance toward a pro-inflammatory state. Since this shift of the immune balance is thought to be beneficial in anti-cancer immunity, we tested the impact of high salt diets on tumor growth in mice. Here we show that high salt significantly inhibited tumor growth in two independent murine tumor transplantation models. Although high salt fed tumor-bearing mice showed alterations in T cell populations, the effect seemed to be largely independent of adaptive immune cells. In contrast, depletion of myeloid-derived suppressor cells (MDSCs) significantly reverted the inhibitory effect on tumor growth. In line with this, high salt conditions almost completely blocked murine MDSC function in vitro. Importantly, similar effects were observed in human MDSCs isolated from cancer patients. Thus, high salt conditions seem to inhibit tumor growth by enabling more pronounced anti-tumor immunity through the functional modulation of MDSCs. Our findings might have critical relevance for cancer immunotherapy.https://www.frontiersin.org/article/10.3389/fimmu.2019.01141/fullcancerdietary factorMDSCcancer immunotherapysodium chloride (dietary)